background
treatment
autoimmun
diseas
aim
dampen
autoreact
preserv
normal
immun
function
cell
transcript
factor
dispens
transcript
factor
cell
develop
respons
primari
infect
promot
express
target
gene
includ
ifng
condit
antigen
reencount
result
strongli
express
upon
secondari
stimul
repeat
antigen
encount
occur
memori
recal
respons
autoimmun
selfantigen
recogn
multipl
time
chronic
infect
foreign
antigen
persist
base
previou
find
hypothes
loss
would
protect
anim
autoimmun
maintain
normal
respons
pathogen
cn
object
use
condit
mous
allel
driver
determin
effect
cellspecif
loss
autoimmuneand
viralinduc
neuroinflamm
use
autoantigendriven
eae
model
autoimmun
jhmv
model
viral
infect
result
condit
delet
mitig
clinic
score
reduc
infiltr
cell
cytokin
product
eae
model
consist
cell
stimul
vitro
show
increas
express
marker
associ
cell
anergi
particularli
absenc
costimulatori
signal
contrast
antivir
cell
effector
function
intact
absenc
chang
neuroinflamm
infiltr
cell
cytokin
product
conclus
find
uncov
signific
differ
effect
loss
autoimmun
antipathogen
respons
potenti
could
exploit
therapeut
benefit
multipl
sclerosi
ms
chronic
debilit
neurolog
diseas
character
inflamm
demyelin
neuron
damag
caus
inappropri
respons
host
immun
system
toward
cell
central
nervou
system
cn
although
pathophysiolog
ms
entir
understood
activ
ms
lesion
character
cn
infiltr
cellsarrang
around
peripheri
activ
ms
lesionsand
cell
typic
perivascular
subsequ
activ
microgli
cell
macrophag
b
cell
cell
thought
master
regul
immun
respons
ms
wherea
perivascular
cell
microgli
cell
macrophag
even
neutrophil
larg
mediat
white
matter
damag
genomewid
associ
studi
gwa
pinpoint
major
histocompat
complex
mhc
gene
locat
human
leukocyt
antigen
hla
region
strongest
influenc
diseas
emphas
import
cell
ms
pathophysiolog
poudomain
transcript
factor
mice
dispens
cell
develop
respons
primari
infect
import
format
central
memori
cell
consequ
cell
lack
complet
defect
memori
recal
respons
memori
cell
highli
prone
make
proinflammatori
cytokin
memori
memorylik
cell
underli
autoimmun
includ
even
case
persist
selfantigen
exposur
vitro
cofactor
ocab
coordin
control
larg
cohort
critic
direct
target
gene
lymphocyt
includ
ifng
tbet
gmcsf
ico
interestingli
ocab
dispens
baselin
activ
gene
exampl
cell
lack
due
germlin
condit
delet
develop
normal
express
normal
level
key
cell
effector
cytokin
gene
upon
primari
stimul
instead
ocab
strongli
regul
gene
condit
antigen
reencount
secondari
stimul
rest
previous
activ
cell
result
express
defect
cell
polar
work
togeth
anoth
transcript
factor
ctcf
mediat
physic
commun
ifng
target
loci
cofactor
also
link
central
memori
cell
format
function
format
cell
cumul
find
point
potent
role
ocab
control
cell
respons
specif
circumst
involv
repeat
antigen
exposur
normal
develop
stimul
respons
form
part
potenti
therapeut
window
target
associ
pathway
could
use
treat
autoimmun
respons
spare
normal
immun
function
addit
immun
memori
repeat
antigen
encount
also
occur
situat
chronic
infect
graftversushost
diseas
tumor
immun
autoimmun
case
latter
human
gwa
studi
show
strong
associ
polymorph
bind
site
predisposit
autoimmun
diseas
includ
rheumatoid
arthriti
celiac
diseas
diabet
ulcer
coliti
autoimmun
thyroid
ms
strong
associ
process
govern
neuroinflammatori
diseas
ms
particular
lead
us
consid
role
neuroinflammatori
cell
respons
autoantigen
viral
infect
show
loss
cell
greatli
attenu
clinic
respons
cell
infiltr
cytokin
product
murin
experiment
autoimmun
encephalomyel
eae
model
maintain
immun
respons
jhmv
infect
eae
autoantigendriven
prototyp
mous
model
ms
decreas
clinic
respons
associ
chang
express
anergyassoci
surfac
protein
cell
upon
stimul
vitro
particular
absenc
costimulatori
signal
use
model
neuroinflamm
induc
intracrani
infect
neurotrop
jhm
strain
mous
hepat
viru
jhmv
observ
differ
clinic
score
infiltr
cell
macrophag
cytokin
express
viral
clearanc
slow
complet
anim
cell
cumul
result
suggest
target
pathway
involv
cell
may
provid
novel
therapeut
avenu
treatment
ms
neuroinflammatori
diseas
larg
spare
benefici
immun
function
mice
use
studi
j
strain
background
condit
mice
cross
previous
describ
anim
experi
approv
univers
utah
institut
anim
care
use
committe
eae
initi
use
myosin
oligodendrocyt
protein
mog
bordetella
pertussi
toxin
pt
method
briefli
mice
subcutan
inject
mog
peptid
mevgwyrspfsrvvhlyrngk
synthes
univers
utah
hsc
core
complet
freund
adjuv
cfa
sigma
mgml
two
hundr
nanogram
pt
sigma
inject
mice
twice
intraven
clinic
score
determin
base
follow
criteria
clinic
diseas
loss
tail
tonic
mild
hind
limb
paresi
moder
hind
limb
paralysi
paraplegia
quadriplegia
coma
death
tissu
analysi
anim
sacrif
peak
diseas
day
leukocyt
isol
spinal
cord
cervic
lymph
node
use
percol
gradient
method
briefli
tissu
dissoci
grind
pass
nylon
strainer
cell
centrifug
percol
room
temperatur
cell
interfac
percol
taken
intracellular
stain
isol
cell
stimul
pma
sigma
ngml
ionomycin
sigma
along
brefeldin
golgi
plug
bectondickenson
h
fix
cell
fixationpermeabil
solut
bd
cytofixcytoperm
tm
accord
manufactur
protocol
antibodi
use
flow
cytometri
follow
fitc
conjug
antimous
biolegend
percp
conjug
antimous
apcconjug
antimous
peconjug
antimous
ebiosci
spleen
harvest
flfl
control
anim
day
inocul
mog
peptid
cfa
singlecel
suspens
prepar
grind
spleen
strainer
cell
isol
mous
cell
isol
kit
miltenyi
biotec
isol
cell
cultur
describ
previous
stimul
platebound
bd
bioscienc
antibodi
ebiosci
h
intracrani
ic
inject
agematch
week
mice
differ
genotyp
anesthet
intraperiton
ip
inject
mixtur
ketamin
hospira
lake
forest
il
usa
xylazin
phoenix
pharmaceut
saint
joseph
mo
usa
hank
balanc
salt
solut
hbss
mice
inject
ic
plaqueform
unit
pfu
jhmv
strain
suspend
hbss
clinic
sever
assess
use
previous
describ
score
scale
analysi
viral
titer
mice
sacrif
indic
time
point
one
half
brain
homogen
use
plaqu
assay
perform
use
dbt
mous
astrocytoma
cell
line
immunophenotyp
immun
cell
present
within
brain
spinal
cord
jhmvinfect
mice
defin
time
postinfect
pi
accomplish
homogen
isol
tissu
gener
singlecel
suspens
analysi
flow
cytometri
use
previous
describ
procedur
brief
isol
cell
stain
follow
antibodi
apcconjug
rat
antimous
peconjug
tetram
specif
immunodomin
epitop
present
within
jhmv
matrix
glycoprotein
span
amino
acid
tetram
determin
total
virusspecif
cell
respect
apcconjug
rat
antimous
peconjug
tetram
specif
immunodomin
epitop
present
spike
glycoprotein
span
amino
acid
identifi
total
virusspecif
cell
respect
tetram
synthes
nih
tetram
core
facil
apcconjug
rat
antimous
peconjug
determin
total
tregulatori
cell
rat
antimous
fitcconjug
identifi
macrophag
sampl
analyz
use
bd
lsr
fortessa
flow
cytomet
flowjo
softwar
spinal
cord
isol
defin
time
point
fix
overnight
paraformaldehyd
section
subsequ
cryoprotect
sucros
day
separ
coron
section
embed
optimum
cut
temperatur
oct
formul
vwr
radnor
pa
usa
coron
section
thick
cut
section
stain
luxol
fast
blue
lfb
combin
hematoxylin
eosin
h
e
area
total
white
matter
demyelin
white
matter
determin
imag
j
softwar
percent
demyelin
calcul
divid
area
demyelin
white
matter
total
white
matter
area
use
establish
method
previous
describ
error
bar
denot
sem
student
test
use
ascrib
statist
signific
figur
p
valu
p
valu
determin
effect
cell
pathogenesi
neuroautoimmun
diseas
use
cell
condit
mice
flfl
control
mice
flfl
conjunct
mogea
model
ms
follow
inocul
peptid
correspond
myelin
oligodendrocyt
glycoprotein
mog
see
method
freund
complet
adjuv
pertussi
toxin
inject
mice
increas
bloodbrain
barrier
permeabl
diseas
sever
determin
evalu
clinic
score
mice
develop
clinic
symptom
day
mog
inject
shown
fig
flfl
mice
significantli
protect
clinic
score
less
control
flfl
mice
exhibit
much
higher
clinic
involv
peak
point
diseas
day
fig
addit
collect
spinal
cord
histopatholog
score
day
eae
induct
degre
demyelin
control
mice
doubl
flfl
group
fig
c
result
reveal
delet
cell
strongli
protect
mice
clinic
symptom
mogea
model
ms
cell
indispens
pathogenesi
eae
ms
express
cnsinfiltr
cell
eae
correl
clinic
sever
cell
contribut
clinic
histolog
diseas
cell
recruit
lesion
mediat
destruct
oligodendrocyt
axon
therefor
screen
cell
popul
drain
cervic
lymph
node
cln
spinal
cord
condit
control
mice
peak
diseas
progress
determin
cell
lack
reduc
autoimmun
activ
cn
cln
although
percentag
cln
similar
group
fig
e
left
panel
fewer
p
total
cell
detect
flfl
group
compar
control
flfl
mice
fig
right
panel
result
suggest
reduc
lymph
node
cellular
eae
model
cell
primari
induc
eae
model
also
profil
cytokin
product
cell
frequenc
total
number
cell
reduc
cln
flfl
mice
compar
flfl
control
fig
g
cln
frequenc
cell
similar
spinal
cord
flfl
flfl
mice
fig
total
number
cell
also
similar
flfl
flfl
mice
shown
howev
cln
proinflammatori
cytokin
product
strongli
reduc
infiltr
cell
spinal
cord
flfl
mice
compar
control
fig
data
indic
loss
cell
strongli
protect
anim
clinic
symptom
eae
protect
associ
decreas
cn
cell
proinflammatori
cytokin
express
cell
anergi
peripher
toler
mechan
induc
tcr
stimul
absenc
costimulatori
signal
cell
becom
poorli
reactiv
protect
anim
potenti
autoreact
loss
result
decreas
express
target
gene
ifng
select
context
repeat
cell
stimul
gene
express
profil
use
cell
defici
cofactor
ocab
reveal
gene
downregul
also
identifi
increas
express
gene
associ
anergi
eg
anerg
respons
model
vitro
provid
cell
primari
tcr
simul
via
immobil
monoclon
antibodi
absenc
costimul
determin
effect
loss
anerg
respons
harvest
cell
consist
mostli
preactiv
rest
cell
spleen
flfl
control
flfl
anim
restimul
h
ex
vivo
use
antibodi
without
costimul
profil
express
protein
associ
activ
anergi
ico
induc
cell
costimul
import
complex
role
induct
cell
anergi
vitro
develop
autoimmun
vivo
analyz
ico
express
flow
cytometri
found
baselin
ico
level
higher
cell
differ
appar
fulli
stimul
cell
receiv
fig
b
interestingli
stimul
cell
alon
result
significantli
reduc
ico
express
cell
compar
control
group
fig
b
increas
baselin
ico
express
rest
cell
decreas
express
upon
anerg
stimul
consist
observ
protect
eae
model
ico
blockad
antigen
prime
day
increas
brain
inflamm
promot
eae
wherea
blockad
later
eae
pathogenesi
day
decreas
cn
leukocyt
infiltr
protect
addit
express
highaffin
receptor
induc
upon
cell
activ
decreas
cell
specif
anerg
condit
lack
costimul
regulatori
cell
treg
express
also
produc
howev
product
cell
similar
control
cell
addit
file
indic
vitro
differ
associ
effector
cell
contrast
express
level
similar
group
fig
result
show
ico
level
alter
cell
manner
consist
observ
protect
eae
model
also
analyz
express
inhibitori
molecul
correl
anerg
respons
express
checkpoint
inhibitor
anergi
marker
see
figur
previou
page
fig
loss
cell
protect
mice
use
eae
model
ms
flfl
n
flfl
n
mice
inject
mog
peptid
pertussi
toxin
gener
eae
clinic
score
determin
posttreat
timecours
b
repres
lfb
stain
thorac
spinal
cord
section
anim
taken
peak
diseas
day
area
demyelin
outlin
red
c
quantif
demyelin
experiment
mice
mean
demyelin
six
section
two
mice
cervic
lymph
node
lymphocyt
isol
eaeinduc
flfl
n
flfl
n
mice
analyz
flow
cytometri
frequenc
cell
repres
anim
shown
e
mean
cell
percentag
left
panel
total
cell
number
right
panel
cell
independ
purifi
cln
six
separ
six
mice
f
repres
data
show
frequenc
cytokineproduc
cell
cln
g
percentag
left
middl
panel
total
cell
number
right
panel
cytokineproduc
cell
plot
n
group
mean
result
shown
h
mean
cell
percentag
spinal
cord
n
group
cytokineproduc
cell
percentag
left
panel
total
cell
number
right
panel
cell
independ
purifi
spinal
cord
separ
six
mice
increas
loss
anerg
full
activ
condit
fig
f
similarli
doubleposit
cell
frequenc
increas
cell
compar
control
cell
condit
fig
h
hi
hi
cell
associ
anergi
frequenc
fig
vitro
stimul
cell
lack
result
decreas
express
marker
associ
activ
increas
express
marker
associ
anergi
control
cell
stimul
vitro
indic
antibodi
analyz
flow
cytometri
repres
frequenc
icosexpress
cell
shown
b
quantif
cell
independ
purifi
spleen
three
mice
three
technic
cultur
replic
mous
c
repres
flow
cytometri
plot
show
frequenc
cell
control
cell
quantif
three
anim
e
repres
express
cell
plot
histogram
control
cell
f
percentag
three
anim
three
cultur
replic
per
anim
plot
g
express
control
cell
h
averag
percentag
hi
hi
cell
plot
produc
cell
differenti
cultur
condit
also
measur
investig
loss
affect
cytokin
express
level
differ
observ
day
stimul
mog
peptid
data
shown
thu
vitro
stimul
cell
lack
result
decreas
express
surfac
protein
associ
activ
increas
express
protein
associ
anergi
find
suggest
target
could
viabl
therapeut
strategi
ms
prior
find
use
acut
infect
model
pathogen
lcmv
indic
cell
dispens
pathogen
respons
clearanc
necessari
robust
memori
recal
respons
howev
role
neuroinflamm
caus
neurotrop
virus
test
significantli
increas
patholog
case
jhmv
would
suggest
target
directli
treatment
autoimmun
result
unwant
side
effect
determin
whether
mediat
diseas
sever
viralinduc
encephalomyel
studi
respons
jhmv
jhmv
glialtrop
coronaviru
wellaccept
model
viralinduc
encephalomyel
immunemedi
demyelin
intracrani
inocul
mice
jhmv
typic
result
acut
encephalomyel
immunemedi
demyelin
hind
limb
paralysi
cell
respons
critic
control
jhmv
replic
within
cn
agematch
flfl
flfl
mice
intracrani
ic
inocul
jhmv
pfu
sever
clinic
diseas
surviv
monitor
jhmvinfect
flfl
mice
demonstr
differ
clinic
diseas
sever
day
fig
viral
titer
brain
jhmvinfect
flfl
compar
control
mice
studi
defin
time
pi
although
viral
titer
elev
cn
day
pi
flfl
mice
compar
control
anim
day
pi
viral
titer
level
detect
pfug
tissu
group
fig
result
indic
viral
clearanc
intact
celldefici
mice
support
find
observ
similar
degre
demyelin
peak
diseas
day
pi
endpoint
day
pi
fig
number
infiltr
fig
b
cell
fig
flfl
mice
compar
control
mice
similar
furthermor
use
tetram
stain
observ
signific
differ
virusspecif
cell
fig
f
cell
fig
h
also
differ
percentag
cell
macrophag
accumul
within
cn
jhmvinfect
mice
time
point
data
shown
studi
proinflammatori
cytokin
express
cn
cell
anim
euthan
day
pi
observ
signific
level
express
shown
consist
prior
find
cell
play
promin
role
model
cell
present
howev
observ
signific
differ
either
percentag
number
degre
product
fig
j
togeth
data
suggest
loss
cell
impact
neurolog
diseas
immunemedi
demyelin
cell
function
respons
jhmv
infect
cn
show
express
transcript
factor
cell
promot
cn
autoimmun
use
mogea
model
minim
particip
cn
antivir
immun
result
suggest
target
associ
activ
pathway
could
use
treat
autoimmun
spare
viral
pathogendirect
immun
function
mechan
transcript
regul
studi
cell
direct
target
gene
includ
ifng
gmcsf
ico
howev
unlik
nfat
dispens
baselin
activ
gene
stimul
primari
cell
result
normal
level
induct
kinet
key
cell
effector
cytokin
normal
cell
develop
respons
initi
stimul
form
part
potenti
therapeut
window
target
associ
pathway
could
use
treat
autoimmun
respons
minim
side
effect
instead
target
gene
show
sever
defect
express
upon
second
encount
antigen
costimulatori
signal
vivo
cell
lack
mount
normal
respons
acut
viral
pathogen
lcmv
fail
form
memori
cell
appreci
number
memori
cell
form
defect
pathogen
recal
respons
memori
cell
prone
make
proinflammatori
cytokin
memori
memorylik
cell
underli
autoimmun
even
case
persist
selfantigen
exposur
find
strong
associ
human
polymorph
bind
site
predisposit
autoimmun
diseas
includ
ms
suggest
possibl
role
promot
ms
mogea
establish
model
ms
driven
inocul
autoantigen
presenc
proinflammatori
signal
use
model
show
loss
cell
protect
anim
clinic
symptom
eae
protect
associ
decreas
cln
lymphadenopathi
proinflammatori
cytokin
express
well
decreas
cn
cell
infiltr
cytokin
express
cell
toler
induc
central
thymic
select
peripher
due
activ
induc
treg
induct
anergi
found
stimul
cell
lack
alon
mimic
tcr
stimul
absenc
costimulatori
signal
significantli
increas
sign
anergi
compar
control
cell
decreas
ico
level
observ
cell
absenc
costimul
wherea
differ
observ
costimul
ico
costimulatori
molecul
express
activ
cell
import
complex
role
induct
cell
anergi
vitro
develop
autoimmun
vivo
block
ico
antigen
prime
promot
eae
wherea
block
ico
later
diseas
cours
protect
interestingli
addit
decreas
ico
level
observ
upon
anerg
stimul
found
unstimul
cell
lack
express
baselin
ico
higher
level
observ
therefor
consist
observ
protect
eae
model
cell
also
show
higher
level
inhibitori
receptor
anerg
marker
find
also
reveal
dispens
clinic
respons
jhmvinduc
neurolog
diseas
clinic
score
demyelin
superimpos
model
express
acceler
necessari
effect
viral
control
howev
total
antivir
cell
number
cytokin
express
macrophag
recruit
broadli
unaffect
exampl
includ
cell
percentag
well
number
cytokineexpress
cell
regulatori
cell
see
figur
previou
page
fig
normal
immun
respons
celldefici
mice
jhmv
infect
flfl
flfl
mice
infect
ic
pfu
jhmv
sacrif
day
n
n
n
pi
assess
cell
infiltr
brain
repres
flow
analysi
depict
cell
infiltr
brain
mice
day
pi
b
quantif
cell
shown
calcul
frequenc
number
isol
cell
c
repres
flow
analysi
depict
cell
infiltr
brain
mice
day
pi
quantif
cell
shown
calcul
frequenc
number
isol
cell
e
repres
tetram
stain
cell
brain
jhmvinfect
experiment
mice
f
quantif
frequenc
number
tetram
cell
experiment
group
g
repres
tetram
stain
cell
brain
jhmvinfect
experiment
mice
h
quantif
frequenc
number
tetram
cell
experiment
group
data
present
deriv
two
independ
experi
day
pi
flfl
n
flfl
mice
n
day
pi
flfl
n
flfl
mice
n
left
panel
right
panel
cnsinfiltr
cell
percentag
shown
repres
anim
j
averag
frequenc
left
panel
total
cell
number
right
panel
cell
analyz
b
n
group
